Delivery Order SPE2DB20D3101-SPE2DB25FRCM1

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,034.57, is a delivery order contract to provide Valacyclovir HCL 1 gram tablets. The contract has an ultimate completion date of January 13, 2025 and is a firm-fixed price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,406.66, was issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the provision of Valacyclovir HCL 1 gram tablets. The contract is a delivery order classified as a firm fixed-price arrangement, with a performance period through May 28, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,446.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valacyclovir HCL 1 gram tablets in 90-count packages. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 22, 2024. The award was not designated under any set-aside program, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,619.15 firm fixed-price delivery order contract is for the supply of 4,563,500 units of 500 mg Valacyclovir HCL tablets. The contract has a period of performance through February 1, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is for pharmaceutical and medical supply delivery orders placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,978.26 firm fixed-price contract covers the delivery of Valtrex 1 GM caplets for the period through February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,062.41 firm fixed price delivery order is for the supply of the pharmaceutical drug Valacyclovir Hydrochl. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,938.07, is for the delivery of Valacyclovir HCL 1 gram tablets in quantities of 90. The contract is a firm-fixed-price Delivery Order that does not have a set-aside designation. It is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $18,094.53 for the supply of Valacyclovir 500mg tablets. The award has an ultimate completion date of October 12, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4566142810 VALACYCLOVIR 1GM 90S, a pharmaceutical product. The fixed-price delivery order, valued at $14,750.77, has an ultimate completion date of November 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,024.62 firm-fixed-price delivery order is for Valacyclovir HCL 1 gram tablets in quantities of 90. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRCM1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,953.60, is a Firm Fixed Price Delivery Order for the supply of 90 tablets of Valacyclovir HCL 1 Gram. The contract has an ultimate completion date of February 21, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award did not have a set-aside designation, indicating open competition. As a major distributor of pharmaceutical and medical products, Amerisourcebergen plays a critical role in supplying essential medical commodities to federal government agencies, particularly the military and veterans' healthcare systems.

Generated 5/22/25, 8:21 PM